If you've been waiting for GLP-1 prices to come down, the wait is almost over. Multiple forces are converging to push prices lower than ever over the next 18 months.
The Price Drop Timeline
| Date | What Happens | Impact |
|---|---|---|
| Jan 2026 | Oral Wegovy launches at $149/mo | First FDA-approved GLP-1 pill at compounded pricing |
| Apr 2026 | Foundayo (orforglipron) FDA-approved at $149/mo | Second oral GLP-1, no food/water restrictions |
| Jul 2026 | Medicare GLP-1 Bridge launches | $50/month for Medicare beneficiaries |
| Jan 2027 | Novo Nordisk cuts list prices 50% | Wegovy/Ozempic list drops to $675/mo |
| Jan 2027 | IRA negotiated prices take effect | Medicare pays $274/mo for Wegovy/Ozempic |
| Jan 2027 | BALANCE Model launches for Part D | Continued $50/mo Medicare coverage |
| 2027–2028 | 16+ new GLP-1 competitors enter market | Increased competition drives prices lower |
| 2031–2032 | Semaglutide patents expire (US) | Generic semaglutide becomes possible |
What's Driving Prices Down
Competition From Oral GLP-1 Pills
The launch of oral Wegovy ($149/mo) and Foundayo ($149/mo) has created a price floor that compounded providers must compete with. Why pay $200+ for a compounded injection when FDA-approved pills cost $149? This competitive pressure is forcing compounded providers to cut prices — Get Thin MD now offers $119/month with price-locked dosing.
Novo Nordisk's 50% List Price Cut
Starting January 1, 2027, Wegovy, Ozempic, and Rybelsus will have a new list price of $675/month — down from $1,349, $935, and $1,027 respectively. This directly helps patients in high-deductible plans whose out-of-pocket costs are tied to list prices.
Medicare Coverage
For the first time, Medicare will cover GLP-1s for weight loss. The July 2026 Bridge program at $50/month, followed by the BALANCE Model in 2027, opens the market to 14+ million potential Medicare beneficiaries.
What This Means for You Right Now
Don't wait for January 2027. Today's cash-pay prices are already near historic lows:
| Provider | Starting Price | Details |
|---|---|---|
| Get Thin MD | $119/mo | Check Price → Paid link |
| Yucca Health | $149/mo | Check Price → Paid link |
| Novi | $174/mo | Check Price → Paid link |
| Sesame Care | from $199 | Check Price → Paid link |
Key Takeaways
- Novo Nordisk cutting list prices 50% to $675/month in January 2027
- IRA-negotiated Medicare price: $274/month for Wegovy/Ozempic in 2027
- Medicare GLP-1 Bridge: $50/month starting July 2026
- Two oral GLP-1 pills now at $149/month (Wegovy pill + Foundayo)
- Cash-pay compounded options already as low as $119/month
- Prices will continue falling as 16+ competitors enter the market
Compare All GLP-1 Prices
See today's lowest verified prices from vetted telehealth providers.
Compare Prices →